FDA Device Intelligence
HomeIMBED BIOSCIENCES, INC. › Microlyte Matrix

Microlyte Matrix

IMBED BIOSCIENCES, INC. · Model 91006 · UDI-DI 00850019162011

FRO Prescription
1
510(k) clearances
3,144
Adverse events (63 deaths)
82
Recalls
383
Facilities

Description

Microlyte® Matrix is a sterile, single use absorbent polymeric wound matrix composed primarily of polyvinyl alcohol with a polymeric surface coating containing ionic and metallic silver. It has very low amounts of silver, with a maximum of 0.16 mg/sqin. Microlyte® Matrix is intended for the management of wounds. The device is packaged in sterile, sealed single pouches.

Recalls

DateFirmReason
2026-06-08ConvaTec, IncSurgical dressing manufactured out of specification (greater thickness).
2026-04-27Oculus Technologies of Mexico, S.A. de C.V.The recall is being conducted due to corrosion of the internal metallic spring within the sprayer component. This condition is caused by material incompatibility between the produc
2026-01-16Integra LifeSciences Corp. (NeuroSciences)Potential packaging failures, which could lead to a breach in the sterile barrier.
2026-01-16Integra LifeSciences Corp. (NeuroSciences)Potential packaging failures, which could lead to a breach in the sterile barrier.
2026-01-16Integra LifeSciences Corp. (NeuroSciences)Potential packaging failures, which could lead to a breach in the sterile barrier.
2026-01-05Medline Industries, LPMedline has identified that the manufacturer of the sterile saline wound wash may not have manufactured products to meet the minimum required sterility assurance level required for
2026-01-05Medline Industries, LPMedline has identified that the manufacturer of the sterile saline wound wash may not have manufactured products to meet the minimum required sterility assurance level required for
2025-08-05Integra LifeSciences Corp. (NeuroSciences)Packaging failures were identified which could lead to a breach in the sterile barrier.
2025-08-05Integra LifeSciences Corp. (NeuroSciences)Packaging failures were identified which could lead to a breach in the sterile barrier.
2025-08-05Integra LifeSciences Corp. (NeuroSciences)Packaging failures were identified which could lead to a breach in the sterile barrier.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.